Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-4 of 4

Sort by

Sort Order Select

Journal Articles

The differential effects of COX inhibitors on oral cancer cell growth and apoptosis correlate with their ability to downregulate Stat3-dependent survivin expression

Mark Scheper, John J. Sauk, Nikolaos G. Nikitakis

Cancer Res (2006) 66 (8_Supplement): 906.

Published: 15 April 2006

View articletitled, The differential effects of COX inhibitors on oral cancer cell growth and apoptosis correlate with their ability to downregulate Stat3-dependent survivin expression

Journal Articles

Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and Neck

Panomwat Amornphimoltham, Vyomesh Patel, Akrit Sodhi, Nikolaos G. Nikitakis, John J. Sauk, Edward A. Sausville, Alfredo A. Molinolo, J. Silvio Gutkind

Cancer Res (2005) 65 (21): 9953–9961.

https://doi.org/10.1158/0008-5472.CAN-05-0921

Published: 01 November 2005

View articletitled, Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and Neck

Journal Articles

Abrogation of IL-6-mediated JAK/STAT signaling by the cyclopentenone prostaglandin 15-Deoxy-Δ^12,14-Prostaglandin J₂ in oral squamous carcinoma cells

Hessam Siavash, Nikolaos G. Nikitakis, John J. Sauk

Cancer Res (2004) 64 (7_Supplement): 1014.

Published: 01 April 2004

View articletitled, Abrogation of IL-6-mediated JAK/STAT signaling by the cyclopentenone prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2 in oral squamous carcinoma cells

Journal Articles

The Nonsteroidal Anti-inflammatory Drug Sulindac Causes Down-Regulation of Signal Transducer and Activator of Transcription 3 in Human Oral Squamous Cell Carcinoma Cells

Nikolaos G. Nikitakis, Anne W. Hamburger, John J. Sauk

Cancer Res (2002) 62 (4): 1004–1007.

Published: 01 February 2002

View articletitled, The Nonsteroidal Anti-inflammatory Drug Sulindac Causes Down-Regulation of Signal Transducer and Activator of Transcription 3 in Human Oral Squamous Cell Carcinoma Cells

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

The differential effects of COX inhibitors on oral cancer cell growth and apoptosis correlate with their ability to downregulate Stat3-dependent survivin expression

Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and Neck

Abrogation of IL-6-mediated JAK/STAT signaling by the cyclopentenone prostaglandin 15-Deoxy-Δ^12,14-Prostaglandin J₂ in oral squamous carcinoma cells

The Nonsteroidal Anti-inflammatory Drug Sulindac Causes Down-Regulation of Signal Transducer and Activator of Transcription 3 in Human Oral Squamous Cell Carcinoma Cells

Email alerts

AACR Journals

Update search

The differential effects of COX inhibitors on oral cancer cell growth and apoptosis correlate with their ability to downregulate Stat3-dependent survivin expression

Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and Neck

Abrogation of IL-6-mediated JAK/STAT signaling by the cyclopentenone prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2 in oral squamous carcinoma cells

The Nonsteroidal Anti-inflammatory Drug Sulindac Causes Down-Regulation of Signal Transducer and Activator of Transcription 3 in Human Oral Squamous Cell Carcinoma Cells

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Abrogation of IL-6-mediated JAK/STAT signaling by the cyclopentenone prostaglandin 15-Deoxy-Δ^12,14-Prostaglandin J₂ in oral squamous carcinoma cells